ALLMedicine™ Japanese Encephalitis Center

Jan 2nd, 2022 - Japanese encephalitis virus (JEV) belongs to a zoonotic flavivirus and is the main cause of viral encephalitis in humans throughout Asia. During the past two decades, both genotypes I (G) and III (GIII) JEVs co-existed in many Asian countries, and...

Dec 25th, 2021 - The possible impact of viral infections on the development or pathogenesis of neurodegenerative disorders remains largely unknown. However, there have been reports associating the influenza virus pandemic and long-term infection with the Japanese ...

Dec 15th, 2021 - Co-administration of vaccines could be an efficient strategy to increase vaccination uptake and reduce the number of clinic visits. This randomized controlled study aimed to evaluate the immunogenicity and safety of enterovirus 71 (EV71) vaccine c...

Dec 9th, 2021 - Japanese encephalitis virus (JEV), an important neurotropic pathogen, belongs to the genus Flavivirus of the family Flaviviridae and has caused huge threat to public health. It is still obscure regarding the functions of stem-loop (SL) and dumbbel...

Dec 4th, 2021 - Virologic surveillance of Japanese encephalitis virus (JEV) relies on collecting pig blood specimens and adult mosquitoes in the past. Viral RNAs extracted from pig blood specimens suffer from low detecting positivity by reverse transcription PCR ...

Mar 13th, 2010 - This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations...

Jul 27th, 2021 - Open-label, randomized, active controlled Phase 3 study in children aged ≥ 2 months to < 18 years. Subjects aged ≥ 2 months to < 12 months were randomized in a 2:1 ratio to receive IC51 (0.25 ml dose) or Prevnar® as a safety comparator. Children a...

Apr 1st, 2021 - Based on the retrospective registry in Zhejiang Provincial Immunization Information System, healthy children aged 6 years from 5 cohorts were included according to their previous immunization schedules on JE: 3 doses of JEV-I (Group 1), JEV-L+ JEV...

Feb 20th, 2020 - This study will be conducted in two stages. In the DTP booster phase subjects will receive a booster dose of Tritanrix-HepB/Hib-MenAC or Tritanrix-HepB/Hib (active control) at 15 to 24 months in a single-blind manner so that the subjects' parents ...

May 9th, 2017 - KMUH plan a series of medical services to Solomon Islands with the expectation that the health and medical standard in Solomon Islands can be improved by medical interaction and the use of high-tech medical instruments. By collecting data from Sol...

Nov 29th, 2016 - Study participants will be enrolled by age group and will each receive one injection of IMOJEV® on Day 0 given as primary vaccination. They will be assessed for immunogenicity and safety, post-vaccination.

Apr 7th, 2021 - PARIS (Reuters) - Valneva on Tuesday reported positive results for its COVID-19 vaccine in early stage clinical trials and said it planned to launch a Phase Three trial this month. The French drugmaker, whose shot uses the technology behind its li...

Nov 18th, 2020 - Editor's note, 25 November 2020: The reader poll has now closed. The results are published here Novavax Novavax expects to fully enrol phase 3 clinical trials of its NVX-CoV2373 candidate in the UK by the end of November. Trials in the US and Mexi...

Sep 4th, 2020 - A renewed effort to vaccinate service members fighting the global war on terrorism has brought new diagnostic challenges. Vaccinations not generally given to the public are routinely given to service members when they deploy to various parts of th.

Aug 5th, 2020 - (Adds Paris to dateline, recasts with Valneva comments) LONDON/PARIS, Aug 5 (Reuters) - French vaccine maker Valneva said on Wednesday that Britain was committing an initial investment of more than 10 million pounds ($13 million) to increase produ...

Nov 26th, 2019 - (Reuters Health) - Many common travel vaccines don't have known safety risks for pregnant women, although a research review also suggests that evidence is limited for some inoculations. Researchers examined data from trials of common travel vaccin...